Physician profile
Marat V Plotkin
NPI 1881613917
$700.21
in general payments reported to CMS, 2019-2025
14 companies · $13.95 in 2025
The $13.95 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $72.39 · 2021: $119 · 2022: $80.79 · 2023: $140 · 2024: $147 · 2025: $13.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $301.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $218.21 | 2019-2023 | Doc Band |
| Supernus Pharmaceuticals, INC. | $102.08 | 2023 | Qelbree |
| Verrica Pharmaceuticals INC. | $74.28 | 2024 | Ycanth |
| Phadia US INC. | $55.91 | 2019-2024 | Immunocap |
| Merck Sharp & Dohme LLC | $40.07 | 2020-2023 | Vaqta, Vaxneuvance, Vaxelis |
| Pfizer INC. | $36.61 | 2024 | |
| Glaxosmithkline, LLC. | $34.25 | 2019-2022 | |
| Adlon Therapeutics L.P. | $25.30 | 2020 | |
| Ironshore Pharmaceuticals INC. | $24.72 | 2019 | |
| Tempus Ai, INC | $22.71 | 2024 | |
| Cognoa, INC. | $22.16 | 2022 | |
| Shire North American Group INC | $16.34 | 2019 | |
| Lilly USA, LLC | $13.95 | 2025 | Mounjaro, Zepbound |
| Tris Pharma INC | $13.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marat Plotkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.